Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
161 hedge funds and large institutions have $554M invested in Surmodics in 2018 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 72 increasing their positions, 45 reducing their positions, and 29 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 45
0.88% more ownership
Funds ownership: 85.99% → 86.87% (+0.88%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 168 → 161 (-7)
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
35% less capital invested
Capital invested by funds: $857M → $554M (-$303M)
63% less call options, than puts
Call options by funds: $1.91M | Put options by funds: $5.23M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.22M |
| 2 |
State Street
Boston,
Massachusetts
|
+$5.28M |
| 3 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$4.29M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$3.46M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$3.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.02M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$3.53M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$3.47M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.36M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.1M |
SRDX Hedge Fund Activity: Q4 2018 in Review
161 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q4 2018, worth a combined $554M — down 35% from $857M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of SRDX and 23 opened new positions — a net loss of 6 holders — while 45 trimmed existing stakes and 72 added.
The largest buyer was Wellington Management Group, adding an estimated $6.22M. The largest seller was Deutsche Bank, cutting an estimated $7.02M.
- 161 institutional investors held Surmodics (SRDX) as of Q4 2018, down from 168 in Q3 2018.
- Funds reported $554M of Surmodics stock for Q4 2018, down 35% quarter-over-quarter.
- 23 funds opened new Surmodics positions in Q4 2018 and 29 closed out, a net change of -6 holders.
- The largest Surmodics buyer in Q4 2018 was Wellington Management Group, an estimated $6.22M added.
- The largest Surmodics seller in Q4 2018 was Deutsche Bank, an estimated $7.02M sold.
Based on aggregated 13F filings for Q4 2018.